TuHURA Biosciences, Inc.
HURA
$3.23
$0.318510.95%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 1.05M | 2.44M | 1.72M | 783.50K | 795.70K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 5.98M | 7.02M | 5.69M | 3.73M | 3.62M |
Operating Income | -5.98M | -7.02M | -5.69M | -3.73M | -3.62M |
Income Before Tax | -9.52M | -6.66M | -6.00M | -5.58M | -5.27M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -9.52M | -6.66M | -6.00M | -5.58M | -5.27M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -9.52M | -6.66M | -6.00M | -5.58M | -5.27M |
EBIT | -5.98M | -7.02M | -5.69M | -3.73M | -3.62M |
EBITDA | -5.96M | -7.00M | -5.68M | -3.70M | -3.58M |
EPS Basic | -0.21 | -0.15 | -0.14 | -0.09 | -0.43 |
Normalized Basic EPS | -0.08 | -0.10 | -0.09 | -0.05 | -0.27 |
EPS Diluted | -0.21 | -0.15 | -0.14 | -0.09 | -0.43 |
Normalized Diluted EPS | -0.08 | -0.10 | -0.09 | -0.05 | -0.27 |
Average Basic Shares Outstanding | 44.56M | 43.40M | 42.32M | 76.37M | 12.18M |
Average Diluted Shares Outstanding | 44.56M | 43.40M | 42.32M | 76.37M | 12.18M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -0.03% | -- | -- | -- |